Introduction: The tetanus-diphtheria vaccine administered during pregnancy is used as a toxoid vaccine with an intact antigen structure. In this study, we investigated the association of tetanus-diphtheria vaccination (TDV) during pregnancy with adverse maternal and neonatal outcomes and particularly preeclampsia that may occur during pregnancy. Materials and Methods: From the patients who presented to our clinic between 01.01.2016 and 31.12.2016 and underwent a cesarean section, a total of 435 patients, 327 who received TDV and 108 who did not receive TDV, were included in the study. The groups were compared with respect to their demographic characteristics. The patient data on the gestational week, birth weight, normal newborn, preeclampsia, small for gestational age (SGA), early membrane rupture, preterm labor, diabetic mother's baby, prematurity, temporary neonatal tachypnea, newborn's need for intensive care, and neonatal mortality were recorded. Results: While 14.7% of the women who had been administered TDV had preeclampsia diagnosis during their pregnancy, 12% of those who had not been vaccinated were diagnosed with preeclampsia. This showed no significant correlation between having been vaccinated during pregnancy and preeclampsia (p = 0.474). The other outcomes we had specified had also no statistically significant correlations with vaccination during pregnancy. Having been vaccinated during pregnancy was found correlated only with the place of residence and nulliparity (p = 0.004 and p = 0.002, respectively).
Introduction
Preeclampsia is defined as a new onset of hypertension and proteinuria or hypertension and target organ dysfunction with/without proteinuria after the 20 th gestational week in a previously normotensive pregnant woman [1] . It has been realized today that proteinuria does not necessarily accompany preeclampsia in some pregnant women with this disease [2] . For this reason, the American
College of Obstetricians and Gynecologists (ACOG) proposed in 2013 some other diagnostic criteria mentioned below, but proteinuria remains to be a major diagnostic criterion [3] . Being an anaerobic gram-positive bacterium, Clostridium tetani thrives in dirt, dust and digestive systems of some animals. Tetanus is caused by a neurotoxin originating from C. tetani in contaminated wounds [4] . Neonatal tetanus kills approximately 500,000 infants every year. Additionally, 15,000 -30,000 women worldwide are reported to die due to tetanus annually.
The cause of this disease is the development of wound infection due to after delivery, miscarriage or surgery. Approximately 50 incidences of tetanus are reported in the USA every year and most of these involve those over 60 years of age, but some incidences can be seen also in children and newborns [5] . Routinely practiced in many countries as a vaccination scheme during pregnancy to prevent neonatal tetanus, which is so important in protecting public health, of tetanus-diphtheria vaccination (TDV) is also being questioned with no clear-cut answer for constituting a risk factor for preeclampsia by contributing the pathogenesis of other diseases during pregnancy while it prevents neonatal tetanus, which has a high level of infective morbidity and mortality. With this study, it was planned to assess whether or not TDV has any impact on maternal and neonatal outcomes and particularly on the probability of developing preeclampsia.
Materials and Methods
In this study, the Ondokuz Mayıs University School of Medicine, Samsun, Turkey's regional data are used. From the patients who presented to our clinic between 01.01.2016 and 31.12.2016 and underwent a cesarean section, a total of 435 patients, 327 who received TDV and 108 who did not receive TDV, were included in the study. We have conducted this study using one-year patient data.
We haven't calculated minimum sample size. The patient data on the gestational week, birth weight, normal newborn, presence of preeclampsia, SGA, early membrane rupture, preterm labor, diabetic mother's baby, prematurity, temporary neonatal tachypnea, newborn's need for intensive care and neonatal mortality were recorded. From the file records of the patients who were diagnosed with preeclampsia, their diagnoses were checked in line with the ACOG 2013 rec- from which we could confirm whether or not they had TDV during their pregnancy, who had a pregnancy involving fetal congenital malformation, those whose pregnancy was earlier than the 24 th gestational week, and those who had intrauterine death or multiple pregnancy were excluded from the study. Every patient was phoned to inform them about the study and to ask if they were willing to take part in the study. Those who volunteered were asked first if they had TDV during their pregnancy, and if they did, when and how many doses of it they had. The women answered by checking their vaccination statuses from their current vaccine tracking cards. Those who did not remember whether or not they had the vaccination were excluded from the study. The patients were then asked if they had TDV before their pregnancy for some reason. However, since a large percentage of them did not remember it, our study was designed without taking prior vaccinations into consideration. Subsequently, information on their residences, prenatal weights, heights, pregnancy treatments, known diseases and smoking statuses and the drugs they used during their pregnancy was obtained.
The diagnostic information on the mother and newborn, patient anamneses, 
Results
From the 435 patients in the study, the number of those who had vaccination during their pregnancy was 327 and that of those who did not have vaccination 
Discussion
Vaccines are antigenic preparations that generally contain weakened or killed infectious agents and toxins to stimulate an immune response. Vaccination against diseases has been a matter of dispute for years in the world of science.
Causing an increase in inflammatory cytokines (IL-6, TNF-α) and a decrease in anti-inflammatory cytokines (IL-10), antigenic agents entering the body may lead to a changed immune response, increased anti-angiogenic response, abnormal trophoblast invasion and increased oxidative stress, resulting in preeclampsia. Maternal infections and particularly urinary infections, as well as periodontal disease, have been reported to increase the risk of preeclampsia [6] . For this reason, pathogens may serve as major activators of the inflammatory process in preeclampsia. Through the same mechanisms, tetanus vaccine can be thought of having an impact on the etiopathogenesis of preeclampsia. More than one factor is agreed to play a role in the development of preeclampsia. The factors considered important today include placenta implantation involving abnormal trophoblastic invasion to uterine vessels, unbalanced immunological tolerance between maternal-paternal (placental) and fetal tissues, failure in maternal adaptation to the cardiovascular or inflammatory changes of a normal pregnancy, and genetic factors [7] . The immunological and physiological changes occurring in pregnancy may alter the vulnerability of the mother and the fetus to some infectious diseases, increasing the risk of producing more serious out- The most suitable time for diphtheria, tetanus and acellular pertussis vaccines is considered to be within the third trimester or at least 2 weeks before birth to allow adequate maternal antibody response [12] . The safety of tetanus toxoid vaccine as evidenced in the last 40 years, as well as the 90% decrease in tetanus-related neonatal mortality, has promoted ideas supporting the use of vaccines during pregnancy [13] . To eradicate maternal and neonatal tetanus, tetanus toxoid (TT) and TDV vaccines are recommended during pregnancy especially in developing countries. In a study comparing TDV and TT in pregnant women, no difference was found in the local (redness and swelling in the injection site) or systemic (fever, weakness, body pain, headache) side effects [14] . Open Journal of Obstetrics and Gynecology outcomes of women who had TDV after their 32 nd gestational week. In their study including a total of 7378 women, 7152 vaccinated and 226 unvaccinated, they did not find any differences between the groups in stillbirths, major malformations, chorioamnionitis, 5 th minute Apgar score or cord blood pH, nor in neonatal complications including newborn's ventilation need, sepsis, intraventricular bleeding and neonatal mortality; they were similar to each other. However, preterm birth rates, SGA incidences, and newborn's hospital stay were significantly more in the unvaccinated group. The authors argued that the increase in the preterm births after gestational week 32 in women who refused vaccination could relate to the fact that such women had less opportunity for an antepartum vaccine administration. A comparison of the women who had at least 2 TDVs (n = 1229) and those who had only 1 dose (n = 4159) in the past 5 years
showed that there was a small but significant increase in the mean birth weight in favor of the women who had more than one TDV, but there was no difference in neonatal outcomes [15] . with cesarean section, low birth weight or neonatal kidney failure [22] . We also made a comparison between the groups in our study on patients with similar characteristics with respect to gestational week, birth weight, newborn health condition, small for gestational age (SGA), early membrane rupture, preterm labor, diabetic mother's baby, prematurity, temporary neonatal tachypnea, newborn's need for intensive care and neonatal mortality and we obtained similar results. The limitations of the study were that the study was retrospective, that the data contained only the results of one region, and that we did not have any data to evaluate the long-term neonatal results between the groups.
Conclusion
No significant correlation was found in this study between TDV administered during pregnancy and adverse gestational outcomes. Vaccination during pregnancy was found correlated with the place of residence. While 82.2% of those Open Journal of Obstetrics and Gynecology living in urban areas had the vaccination, only 70% of those living in rural areas were vaccinated. The lower rate of vaccination in rural areas may be associated with the restrictions in having access to health services in the periphery. A statistically significant correlation was found also between nulliparity and vaccination status. While the rate of vaccination was 69.5% in multiparae, it was 82.1% in nulliparae. This may be associated with the fact that women who had their first pregnancy attend health checks more regularly. There are very few studies investigating the relationship between diphtheria-tetanus vaccination during pregnancy and development of preeclampsia. Our study demonstrated the fact that women who had TDV during their pregnancy do not exhibit a significant difference in maternal and neonatal outcomes as compared to those who were unvaccinated.
